Skip to main content
An official website of the United States government

fluorine F 18 FEQA

The anilinoquinazoline derivative FEQA radiolabeled with the positron-emitting radioisotope fluorine F 18 with epidermal growth factor receptor (EGFR) binding and radioisotopic activities. Fluorine F 18 FEQA irreversibly binds to (EGFR), allowing imaging of EGFR-positive tumor cells with positron emission tomography (PET).
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Abbreviation:F-18 FEQA
Chemical structure:N-{4-[(3'- [F-18] fluoroethylphenyl)amino]-6-quinazolinyl}-acrylamide
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search